Team behind RECOVERY trial of COVID drugs casts its net wider
pharmaphorum
JANUARY 24, 2022
The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 million in funding from French drugmaker Sanofi.
Let's personalize your content